- Home
- Automated
- List of product information
- IMDEX CR TABLET 60 MG [SIN10515P]
IMDEX CR TABLET 60 MG [SIN10515P]
Active ingredients: IMDEX CR TABLET 60 MG
Product Info
IMDEX CR TABLET 60 MG
[SIN10515P]
Product information
Active Ingredient and Strength | ISOSORBIDE-5-MONONITRATE - 60 MG |
Dosage Form | TABLET, FILM COATED |
Manufacturer and Country | DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. - MALAYSIA |
Registration Number | SIN10515P |
Licence Holder | DUOPHARMA (SINGAPORE) PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | C01DA14 |
INDICATIONS
Imdex™ tablets are indicated for the prophylaxis and long-term treatment of angina pectoris due to coronary artery disease.
RECOMMENDED DOSAGE, DOSAGE SCHEDULE AND ROUTE OF ADMINISTRATION
Adult dose:
Imdex™ 60 mg, once daily to be taken in the morning. The dose may be increased to 120 mg once daily in the morning. To minimise the possibility of headache, treatment can be initiated with 30 mg for the first 2–4 days. Whole tablet of Imdex™ 60 mg and 30 mg tablets should be swallowed with half a glass of fluid. If required, the divided half of Imdex™ 60 mg should also be taken in the same manner. Care has to be taken to avoid crushing or chewing the tablet, in order for half tablet doses to be administered without affecting its sustained release properties.
Dosage of elderly:
The dosage of nitrates in cardiovascular disease is usually determined by patient response and stabilisation. However, caution may be required in elderly patients who are known to be susceptible to the effects of hypotensive medication.
Children:
The safety and efficacy of Imdex™ in children has not been established.
CONTRAINDICATIONS
Isosorbide-5-mononitrate is contraindicated in patients who are allergic to nitrates and in cases of low blood pressure, hypovolaemia, shock, marked anaemia, closed-angle glaucoma and raised intracranial pressure due to head trauma or cerebral haemorrhage.
Imdex™ should also not be used in patients with hypertrophic obstructive cardiomyopathy, aortic stenosis, cardiac temponade, constrictive pericarditis, mitral stenosis and acute myocardial infarction with low left ventricular filling pressure.
